These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10930799)

  • 1. Combination raltitrexed (Tomudex(R))-oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma.
    Fizazi K; Caliandro R; Soulié P; Fandi A; Daniel C; Bedin A; Doubre H; Viala J; Rodier J; Trandafir L; Le Chevalier T; Cvitkovic E; Armand J; Ruffié P
    Eur J Cancer; 2000 Aug; 36(12):1514-21. PubMed ID: 10930799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of antifolates in the treatment of malignant pleural mesothelioma.
    Fizazi K; John WJ; Vogelzang NJ
    Semin Oncol; 2002 Feb; 29(1):77-81. PubMed ID: 11836672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
    Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
    J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
    Armand JP; Seymour L; Evans TR
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.
    Fizazi K; Ducreux M; Ruffié P; Bonnay M; Daniel C; Soria JC; Hill C; Fandi A; Poterre M; Smith M; Armand JP
    J Clin Oncol; 2000 Jun; 18(11):2293-300. PubMed ID: 10829050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raltitrexed: current clinical status and future directions.
    Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
    Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
    Scheithauer W; Kornek GV; Ulrich-Pur H; Penz M; Raderer M; Salek T; Haider K; Kwasny W; Depisch D
    Cancer; 2001 Apr; 91(7):1264-71. PubMed ID: 11283925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.
    Porta C; Zimatore M; Bonomi L; Imarisio I; Paglino C; Sartore-Bianchi A; Mutti L
    Lung Cancer; 2005 Jun; 48(3):429-34. PubMed ID: 15893013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin and raltitrexed in the treatment of inoperable malignant pleural mesothelioma: results of a pilot study.
    Maisano R; Caristi N; Toscano G; Aragona M; Spadaro P; Amadio P; Mare M; Zavettieri M; La Torre F
    Tumori; 2001; 87(6):391-3. PubMed ID: 11989592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raltitrexed in mesothelioma.
    Surmont VF; van Meerbeeck JP
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1481-90. PubMed ID: 21999120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
    Caponigro F; Avallone A; Budillon A; Comella P; Comella G
    Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
    Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
    J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
    Rosati G; Rossi A; Germano D; Reggiardo G; Manzione L
    Anticancer Res; 2003; 23(3C):2981-5. PubMed ID: 12926149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
    Woods B; Paracha N; Scott DA; Thatcher N
    Lung Cancer; 2012 Feb; 75(2):261-7. PubMed ID: 21937141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
    Kasseyet S; Astoul P; Boutin C
    Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed-based chemotherapy for advanced colorectal cancer.
    Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.